Search
Now showing items 1-10 of 40
Feline CTLA-4 nucleic acid and polypeptides
(United States. Patent and Trademark Office, 2010-06-29)
The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
Expression of foreign genes using a replicating polyprotein producing virus vector
(United States. Patent and Trademark Office, 1996-02-13)
The present invention provides an expression vector adapted for expressing heterologous proteins in plants susceptible to a polyprotein-producing plant virus. The vector utilizes the unique ability of viral polyprotein ...
Method for producing a recombinant baculovirus expression vector
(United States. Patent and Trademark Office, 1988-05-17)
A method for producing a recombinant baculovirus expression vector, capable of expression of a selected gene in a host insect cell, is disclosed. The preferred method involves cleaving baculovirus DNA to produce a DNA ...
Nucleic acid encoding feline CD86
(United States. Patent and Trademark Office, 2006-07-18)
The present invention provides isolated and purified DNA encoding feline CD80 (B7-1) ligand, feline CD86 (B7-2) ligand, feline CD28 receptor, or feline CTLA-4 (CD152) receptor, as well as vectors comprising nucleic acid ...
Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots
(United States. Patent and Trademark Office, 2010-07-13)
The invention is directed to isolated promoters from stem-regulated, defense-inducible genes, such as JAS promoters. The promoters are useful in expression cassettes and expression vectors for the transformation of plants. ...
Compositions and methods of enhancing immune responses to Eimeria
(United States. Patent and Trademark Office, 2015-02-17)
Vaccines comprising TRAP polypeptides and Salmonella enteritidis vectors comprising TRAP polypeptides are provided. The vaccines may also include a CD154 polypeptide capable of binding to CD40. Also provided are methods ...
MHC II analog from Staphylococcus aureus
(United States. Patent and Trademark Office, 1997-07-15)
Staphylococcus aureus can bind a number of different extracellular matrix proteins. Recent studies have shown that one particular Staphylococcus protein has the capacity of binding several different matrix proteins. The ...
Cotton plant with seed-specific reduction in gossypol
(United States. Patent and Trademark Office, 2011-08-16)
A method is disclosed for reducing the level of gossypol in cottonseed. The method generally includes selectively inducing RNA gene silencing in the seed of a transgenic cotton plant, to interfere with expression of the ...
Method for transforming plants via the shoot apex
(United States. Patent and Trademark Office, 1992-11-17)
The invention relates to a novel method for transforming and rapidly regenerating plant tissue. The method employs target tissues which are the shoot apices thereby expanding the species range for transformation and reducing ...
Extracellular matrix-binding proteins from staphylococcus aureus
(United States. Patent and Trademark Office, 2004-01-20)
Isolated extracellular matrix-binding proteins, designated ClfB, SdrC, SdrD and SdrE, and their corresponding amino acid and nucleic acid sequences and motifs are described. The proteins, peptides, fragments thereof or ...